Lannan Symposium: February 6-8, 2023 The body, especially the sick, aging, traumatized, disabled, female, black, brown or queer body, is as much the territory of regulation and conflict as the ownership of property or wealth. The Lannan Symposium gathers writers, medical professionals, ethicists, and journalists for a series of nightly discussions, each centering upon the […]
Experts and company leadership to discuss clinical significance of indications driven by muscle atrophy and Ph2 trial design for acute ICU myopathies in older patientsRICHMOND, Calif. (BUSINESS WIRE) #aging BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target th.
Alphagalileo > Item Display alphagalileo.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alphagalileo.org Daily Mail and Mail on Sunday newspapers.
Canadian-led studies suggest blood thinner can help moderately sick COVID-19 patients cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
Cassandra Szklarski March 01, 2021 - 8:46 AM
TORONTO - Alongside the headline-grabbing race for a COVID-19 vaccine, the hunt for effective treatments has unfolded with its own share of flameouts and triumphs.
Thanks to large randomized trials in the United Kingdom and elsewhere, administering steroids to patients with moderate or severe illness has become part of standard care, but clinicians say few other tools have emerged.
The best known COVID-19 drug is likely dexamethasone, a corticosteroid with anti-inflammatory and immunosuppressant effects for hospitalized patients who need help breathing.
But while that drug is credited with helping efforts to bring down hospital mortality rates, credit also goes to discoveries about what does not work against the novel coronavirus â thereby ensuring people get appropriate care.